Literature DB >> 18182782

Evaluation and determinants of underprescription of erythropoiesis stimulating agents in pre-dialysis patients with anaemia.

Nathalie Thilly1, Bénédicte Stengel, Stéphanie Boini, Emmanuel Villar, Cécile Couchoud, Luc Frimat.   

Abstract

BACKGROUND: Inadequate anaemia correction (haemoglobin (Hb) <11 g/dl without receiving an erythropoiesis-stimulating agent (ESA) is common in pre-dialysis patients, but little is known about its determinants. We used data from the French end-stage renal disease (ESRD) registry to investigate these determinants and the patients' anaemia status 1 year after starting dialysis.
METHODS: Pre-dialysis anaemia care was studied in 6,271 incident ESRD patients from 13 regions, who were first treated between 2003 and 2005. Data included pre-dialysis Hb measure and ESA use, patient's condition and modalities of dialysis initiation. Anaemia status at 1 year was studied in 925 patients from four regions who started dialysis in 2003 and 2004, were still on dialysis one year later, and had completed the annual registry data form.
RESULTS: Overall, 34.7% of the patients had inadequate pre-dialysis anaemia correction, with variations across regions from 21.1 to 43.2%. Inadequate anaemia correction decreased from 38.0% in 2003 to 33.2% in 2005. It was less likely in patients with diabetic or polycystic kidney disease and more likely in those with malignancy, unplanned haemodialysis, and low glomerular filtration rate or low serum albumin at dialysis initiation. One year after starting dialysis, inadequate correction concerned only 2.6% of the patients. Hb level had risen from 10.3 g/dl in pre-dialysis to 11.7 g/dl, but remained lower in those with inadequate pre-dialysis correction.
CONCLUSION: Despite improvement over time, inadequate correction with ESAs remains high in pre-dialysis patients in contrast with those on dialysis. As the timing of dialysis initiation is uncertain, continuous management of anaemia is requested. (c) 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18182782      PMCID: PMC3195675          DOI: 10.1159/000112914

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  27 in total

Review 1.  Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease.

Authors:  Madhumathi Rao; Brian J G Pereira
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

Review 2.  The importance of residual renal function in dialysis patients.

Authors:  A Y-M Wang; K-N Lai
Journal:  Kidney Int       Date:  2006-05       Impact factor: 10.612

3.  KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

4.  Nephrology referral and appropriateness of therapeutic drug care in chronic kidney disease.

Authors:  Nathalie Thilly; Stéphanie Boini; Michéle Kessler; Serge Briançon; Luc Frimat
Journal:  J Nephrol       Date:  2006 May-Jun       Impact factor: 3.902

5.  Global approach to cardiovascular risk in chronic kidney disease: reality and opportunities for intervention.

Authors:  L De Nicola; R Minutolo; P Chiodini; C Zoccali; P Castellino; C Donadio; M Strippoli; F Casino; M Giannattasio; F Petrarulo; M Virgilio; E Laraia; B R Di Iorio; V Savica; G Conte
Journal:  Kidney Int       Date:  2006-02       Impact factor: 10.612

6.  Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

Authors:  Tilman B Drüeke; Francesco Locatelli; Naomi Clyne; Kai-Uwe Eckardt; Iain C Macdougall; Dimitrios Tsakiris; Hans-Ulrich Burger; Armin Scherhag
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

7.  Variability in quality of care among dialysis units in western Switzerland.

Authors:  Patrick Saudan; Georges Halabi; Thomas Perneger; Jean-Blaise Wasserfallen; Michel Kossovsky; Harold Feldman; Pierre-Yves Martin; Jean-Pierre Wauters
Journal:  Nephrol Dial Transplant       Date:  2005-07-05       Impact factor: 5.992

8.  National haemodialysis guidelines: an assessment of compliance from 2001-2003.

Authors:  Kym M Bannister; Paul Snelling
Journal:  Nephrology (Carlton)       Date:  2006-04       Impact factor: 2.506

9.  Correction of anemia with epoetin alfa in chronic kidney disease.

Authors:  Ajay K Singh; Lynda Szczech; Kezhen L Tang; Huiman Barnhart; Shelly Sapp; Marsha Wolfson; Donal Reddan
Journal:  N Engl J Med       Date:  2006-11-16       Impact factor: 91.245

10.  The renal epidemiology and information network (REIN): a new registry for end-stage renal disease in France.

Authors:  Cécile Couchoud; Bénédicte Stengel; Paul Landais; Jean-Claude Aldigier; François de Cornelissen; Christian Dabot; Hervé Maheut; Véronique Joyeux; Michèle Kessler; Michel Labeeuw; Hubert Isnard; Christian Jacquelinet
Journal:  Nephrol Dial Transplant       Date:  2005-10-18       Impact factor: 5.992

View more
  3 in total

1.  Hemoglobin variability does not predict mortality in European hemodialysis patients.

Authors:  Kai-Uwe Eckardt; Joseph Kim; Florian Kronenberg; Pedro Aljama; Stefan D Anker; Bernard Canaud; Bart Molemans; Peter Stenvinkel; Guntram Schernthaner; Elizabeth Ireland; Bruno Fouqueray; Iain C Macdougall
Journal:  J Am Soc Nephrol       Date:  2010-08-26       Impact factor: 10.121

2.  Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France, 2007-2011.

Authors:  Frank G A Assogba; Cécile Couchoud; Thierry Hannedouche; Emmanuel Villar; Luc Frimat; Anne Fagot-Campagna; Christian Jacquelinet; Bénédicte Stengel
Journal:  Diabetologia       Date:  2014-02-06       Impact factor: 10.122

3.  [Profile of chronic renal failure in diabetes at initiation of hemodialysis in the nephrology and dialysis service of the military hospital in Rabat, Morocco].

Authors:  Mohamed Reda El Farouki; Abdelaali Bahadi; Mohamed Amine Hamzi; Driss Kabbaj; Mohammed Benyahia
Journal:  Pan Afr Med J       Date:  2013-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.